Ken Stein

9.7k total citations
167 papers, 6.9k citations indexed

About

Ken Stein is a scholar working on Economics and Econometrics, Epidemiology and General Health Professions. According to data from OpenAlex, Ken Stein has authored 167 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Economics and Econometrics, 32 papers in Epidemiology and 30 papers in General Health Professions. Recurrent topics in Ken Stein's work include Health Systems, Economic Evaluations, Quality of Life (34 papers), Clinical practice guidelines implementation (13 papers) and Acute Ischemic Stroke Management (11 papers). Ken Stein is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (34 papers), Clinical practice guidelines implementation (13 papers) and Acute Ischemic Stroke Management (11 papers). Ken Stein collaborates with scholars based in United Kingdom, United States and Belgium. Ken Stein's co-authors include Ruth Garside, Jo Thompson Coon, Rebecca Whear, A Round, Rebecca Abbott, Martin Pitt, Alison Bethel, Kim Dalziel, Rob Anderson and G Rogers and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Ken Stein

164 papers receiving 6.7k citations

Peers

Countries citing papers authored by Ken Stein

Since Specialization

Citations

This map shows the geographic impact of Ken Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Stein more than expected).

Fields of papers citing papers by Ken Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Stein. The network helps show where Ken Stein may publish in the future.

Co-authorship network of co-authors of Ken Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Stein. A scholar is included among the top collaborators of Ken Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Stein. Ken Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An objective neurophysiological study of subconcussion in female and male high school student athletes 2024 ·Scientific Reports ·Ryan C.N. D’Arcy, H. D. McCarthy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shaun D. Fickling, Thayne A. Munce, David W. Dodick, Christopher S. Ahmad, Ken Stein	0
2	Exploring the rise and diversity of health and societal issues that use a public health approach: A scoping review and narrative synthesis 2024 ·SHILAP Revista de lepidopterología ·Alison Hurst, Nick Shaw, Daniele Carrieri, Ken Stein, Katrina Wyatt	1
3	Reviewing the Evidence Base for Topical Steroid Withdrawal Syndrome in the Research Literature and Social Media Platforms: An Evidence Gap Map 2024 ·Journal of Medical Internet Research ·Noreen Orr, Morwenna Rogers, A. Stein, Jo Thompson Coon, Ken Stein	3
4	Jargon and Readability in Plain Language Summaries of Health Research: Cross-Sectional Observational Study 2024 ·Journal of Medical Internet Research ·Iain Lang, Angela G. King, Kate Boddy, Ken Stein, (unknown), Jo Day, Kristin Liabo	1
5	Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study 2023 ·BMJ Open ·Krystal Warmoth, Jessica Rees, Jo Day, Emma Cockcroft, (unknown), (unknown), (unknown), (unknown), (unknown), Ken Stein	2
6	Using simulation and machine learning to maximise the benefit of intravenous thrombolysis in acute stroke in England and Wales: the SAMueL modelling and qualitative study 2022 ·SHILAP Revista de lepidopterología ·Michael Allen, Charlotte James, Julia Frost, Kristin Liabo, (unknown), Thomas Monks, Zhivko Zhelev, Stuart Logan, Richard Everson, Martin James, Ken Stein	5
7	National implementation of reperfusion for acute ischaemic stroke in England: How should services be configured? A modelling study 2021 ·European Stroke Journal ·Michael Allen, (unknown), Gary A. Ford, Phil White, Anthony Rudd, Peter McMeekin, Ken Stein, Martin James	6
8	Understanding stakeholders’ perspectives on implementing deprescribing for older people living in long-term residential care homes: the STOPPING study protocol 2020 ·SHILAP Revista de lepidopterología ·Krystal Warmoth, Jo Day, Emma Cockcroft, Donald N. Reed, (unknown), (unknown), (unknown), (unknown), Ken Stein	1
9	An Implementation Science Perspective on Deprescribing 2018 ·Public Policy & Aging Report ·Charlene Ronquillo, Jo Day, Krystal Warmoth, Nicky Britten, Ken Stein, Iain Lang	9
10	Feasibility of a hyper-acute stroke unit model of care across England: a modelling analysis 2017 ·BMJ Open ·Michael Allen, (unknown), (unknown), Thomas Monks, Ken Stein, Martin James	10
11	Creating psychological connections between intervention recipients: development and focus group evaluation of a group singing session for people with aphasia 2016 ·BMJ Open ·Mark Tarrant, Krystal Warmoth, Chris Code, Sarah Dean, Victoria A Goodwin, Ken Stein, Thavapriya Sugavanam	45
12	Sodium Oxybatefor Narcolepsy with CataplexyâA Cost-Effective Analysis 2014 ·(unknown), (unknown), (unknown), Ken Stein	1
13	The Clinical Effectiveness of Patient Initiated Clinics for Patients with Chronic or Recurrent Conditions Managed in Secondary Care: A Systematic Review 2013 ·PLoS ONE ·Rebecca Whear, (unknown), Kate Boddy, Jo Thompson Coon, Mark Perry, Ken Stein	22
14	The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model 2009 ·Health Technology Assessment ·Mark Bond, Stuart Mealing, Rob Anderson, Julian Elston, Graeme M. Weiner, RS Taylor, Martin Hoyle, (unknown), Alison Price, Ken Stein	239
15	Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over 2008 ·Health Technology Assessment ·Jonathan Shepherd, G Rogers, Ronald Anderson, Caroline Main, Jo Thompson Coon, D Hartwell, (unknown), Emma Loveman, (unknown), Martin Pitt, Ken Stein, P Harris, Geoff K Frampton, Melissa Smith, Andrea Takeda, Alison Price, Karen Welch, Matthew C. Somerville	54
16	Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years 2008 ·Health Technology Assessment ·Caroline Main, Jonathan Shepherd, Ronald Anderson, G Rogers, Jo Thompson Coon, (unknown), D Hartwell, Emma Loveman, (unknown), Martin Pitt, Ken Stein, P Harris, Geoff K Frampton, Michael A. Smith, Andrea Takeda, Alison Price, Karen Welch, Matthew C. Somerville	87
17	Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis 2008 ·British Journal of Cancer ·Jo Thompson Coon, G Rogers, Paul Hewson, D. Wright, Rob Anderson, Simon Jackson, Stephen Ryder, Matthew Cramp, Ken Stein	86
18	Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials 2005 ·BMJ ·Darren M. Ashcroft, Paul W. Dimmock, Ruth Garside, Ken Stein, Hywel C Williams	169
19	Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach 2004 ·Health Technology Assessment ·Sandy Oliver, (unknown), Rebecca Rees, Ruairidh Milne, Phyll Buchanan, John Gabbay, Gillian ML Gyte, Ann Oakley, Ken Stein	320
20	Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. 1996 ·Gut ·R. Arnold, Michael Trautmann, W. Creutzfeldt, R Benning, Mayah Benning, Christoph Neuhaus, (unknown), Ken Stein, H. Schäfer, Christian Bruns, (unknown)	274

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact